about
Strategies for treatment in Alexander diseaseRegulatory role of proteasome in determination of platelet life spanSalinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosisInhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1α protein expression through the ubiquitin-proteasome degradation pathwaySynthesis and proteasome inhibition of lithocholic acid derivativesSubstrate Ubiquitination Controls the Unfolding Ability of the Proteasome.Synthesis of Lithocholic Acid Derivatives as Proteasome RegulatorsThe role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP.Agouti Related Peptide Secreted Via Human Mesenchymal Stem Cells Upregulates Proteasome Activity in an Alzheimer's Disease Model.Basic mechanisms of neurodegeneration: a critical update.Current concepts in scar evolution and control.Proteasome activator 200: the heat is on...Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma.Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence.Boron-Based Drug Design.Proteasome properties of hemocytes differ between the whiteleg shrimp Penaeus vannamei and the brown shrimp Crangon crangon (Crustacea, Decapoda).Gene set analysis of purine and pyrimidine antimetabolites cancer therapiesNoncovalent inhibitors of human 20S and 26S proteasome based on trypsin inhibitor SFTI-1.The proteasome inhibitor bortezomib is a potent inducer of zinc finger AN1-type domain 2a gene expression: role of heat shock factor 1 (HSF1)-heat shock factor 2 (HSF2) heterocomplexes.Investigations on the interactions of λphage-derived peptides against the SrtA mechanism in Bacillus anthracis.Boc3Arg-Linked Ligands Induce Degradation by Localizing Target Proteins to the 20S Proteasome.Defective Protein Catabolism in Atherosclerotic Vascular Inflammation.The 14th International Conference on Alzheimer's Drug Discovery, 9 - 10 September 2013, in Jersey City, New Jersey.Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress.
P2860
Q24596794-ACA904D1-6B1A-4EB5-B159-538CCBC65829Q33405368-0BBD366C-77E9-45B5-8D7A-5AE81A51FF31Q34142223-B5DDCE43-C2FA-414C-B132-72BFAEDD5672Q34249469-ADD37E0A-DB45-4D3D-ACA6-399208889D42Q34455663-F8CD2CF1-A5A7-490C-BAD9-F4DBBF598D2FQ34769338-6D8E206B-6FD9-4F11-A845-482EC2ADBF22Q36074198-1A8C4A5C-A2C6-450E-BAE4-AAC8BFAC66CAQ36529762-8857E7DB-6CFF-44EE-8204-CDDF74E4AC61Q37503447-F73874DF-B1DE-4EA6-A693-7E23792349A5Q37554576-CC78C9BA-7DC2-4BFC-8C6D-DA39B3D78788Q37673274-1F11AF44-DBDB-4732-AED8-CAC691263B8EQ37817045-AC2AD30D-9E03-4CDD-9311-5608B017F1A6Q37851267-EF292EBD-45B8-4182-8099-3EFF6CD2695FQ38111684-0C190F95-273B-45F7-B5CB-5E7FC6B65A37Q38239053-EB9E6716-8217-4A1A-8D48-FF5000572E4CQ38387948-F3191F32-F915-4D85-9FD3-93E4C8EDF83FQ38667315-210BE239-D0BD-4DA3-8121-CE44D7C0C95CQ38690391-D717067F-437F-462F-90A4-82D54D921E30Q38766823-49FBF8C4-E13D-4169-93BD-2B4993DD9170Q39146191-BF05E5D9-49C3-4ACA-939D-54FB77ADA577Q42253860-B4BD5323-472A-47C6-A888-544DD9219127Q47103279-0F1CD14C-17D5-4AC1-9F82-8DDBA64BAFF9Q47132046-B92D1548-EB55-40F3-85B8-1CE13CDE57FBQ53096518-3E8D75CC-684A-4F11-B503-843903FD3ECFQ54957638-A9B5BB8F-C208-42A7-8CAF-BDC098558AF4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteasome regulators: activators and inhibitors.
@en
Proteasome regulators: activators and inhibitors.
@nl
type
label
Proteasome regulators: activators and inhibitors.
@en
Proteasome regulators: activators and inhibitors.
@nl
prefLabel
Proteasome regulators: activators and inhibitors.
@en
Proteasome regulators: activators and inhibitors.
@nl
P2860
P1476
Proteasome regulators: activators and inhibitors
@en
P2093
Chin Ho Chen
P2860
P304
P356
10.2174/092986709787581860
P50
P577
2009-01-01T00:00:00Z